ERNA

Ernexa Therapeutics Inc. ERNA

ERNA
Ernexa Therapeutics Inc. ADAP
Adaptimmune Therapeutics plc MPLT
MapLight Therapeutics, Inc. LNAI
Lunai Bioworks Inc. PMN
ProMIS Neurosciences, Inc. DWTX
Dogwood Therapeutics, Inc. PHGE
BiomX Inc. MBRX
Moleculin Biotech, Inc. AEON
AEON Biopharma, Inc. OSRH
OSR Holdings, Inc.

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode ERNA ADAP MPLT LNAI PMN DWTX PHGE MBRX AEON OSRH
6M -46.53 % -80.83 % 12.05 % -53.95 % -31.60 % 31.63 % -77.95 % -41.62 % 45.16 % -57.73 %
YTD -76.35 % -92.22 % 12.05 % -53.95 % -64.38 % 156.97 % -85.72 % -91.19 % -97.27 % -94.26 %
1Y -64.40 % -91.75 % 12.05 % -53.95 % -62.83 % 137.13 % -79.62 % -90.98 % -97.50 % -94.26 %
3Y -97.48 % -96.58 % 12.05 % -53.95 % -92.83 % 5.22 % -94.25 % -99.17 % -99.84 % -94.26 %
5Y -99.89 % -99.02 % 12.05 % -53.95 % -90.50 % -97.37 % -99.81 % -99.78 % -99.84 % -94.26 %
10Y -99.97 % -99.51 % 12.05 % -53.95 % -85.75 % -98.46 % -99.88 % -99.98 % -99.84 % -94.26 %
From the beginning -100.00 % -99.70 % 12.05 % -53.95 % -99.53 % -98.46 % -99.88 % -99.98 % -99.84 % -94.26 %

Dividend